Zusammenfassung
Es wird häufig von Patientinnen und ihren Partnern nach möglichen Langzeitschäden einer Kinderwunschbehandlung bzw. einer Hormonstimulation gefragt. In diesem Kapitel sollen kurzfristige, mittelfristige und langfristige Risiken behandelt werden. Dabei wird neben den somatischen Aspekten auch die familiäre Gesundheit anhand der verfügbaren Literatur dargestellt.
Literatur
Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, Brinton LA (2005a) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161:607–615
Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA (2005b) Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193:668–674
Balen F van (1998) Development of IVF children. Dev Rev 18:30–46
Barnes J, Sutcliffe AG, Kristoffersen I, Loft A, Wennerholm U, Tarlatzis BC, Kantaris X, Nekkebroeck J, Hagberg BS, Madsen SV et al (2004) The influence of assisted reproduction on family functioning and children's socio-emotional development: results from a European study. Hum Reprod 19:1480–1487
Bjornholt SM, Krüger Kjaer S, Nielsen TSS, Jensen A (2015) Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study. Hum Reprod 30:222–231
Boer EJ de, den Tonkelaar I, Te Velde ER, Burger CW, Klip H, van Leeuwen FE (2002) A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 77:978–985
Boer EJ de, den Tonkelaar I, Te Velde ER, Burger CW, van Leeuwen FE (2003) Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 18:1544–1552
Boer EJ de, den Tonkelaar I, Burger CW, Looman CW, van Leeuwen FE, Te Velde ER (2004) The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Hum Reprod 19:899–904
Braat DD, Bernardus RE, Gerris J (2002) Anonymous reports of lethal cases of ovarian hyperstimulation syndrome. In: Gerris J, Delvigne A, Olivennes F (Hrsg) Ovarian hyperstimulation syndrome. Informa UK, London, S 59–66
Braat DD, Schutte JM, Bernardus RE, Mooij TM, van Leeuwen FE (2010) Maternal death related to IVF in the Netherlands 1984–2008. Hum Reprod 25:1782–1786
Brinton LA, Moghissi KS, Scoccia B, Westhoff CL Lamb EJ (2005) Ovulation induction and cancer risk. Fertil Steril 83:261–274
Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod 28:2813–2821
Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL (2015) Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril 104:980–988
Bryson CA, Sykes DH, Traub AI (2000) In vitro fertilization: a long-term follow-up after treatment failure. Hum Fertil (Cambridge) 3:214–220
Cetin I, Cozzi V, Antonazzo P (2008) Infertility as a cancer risk factor – a review. Placenta 29(Suppl B):169–177
Elder K, Mathews T, Kutner E, Kim E, Espenberg D, Faddy M, Gosden R (2008) Impact of gonadotrophin stimulation for assisted reproductive technology on ovarian ageing and menopause. Reprod BioMed Online 16:611–616
Filetto JN, Makuch MY (2005) Long-term follow-up of women and men after unsuccessful IVF. Reprod BioMed Online 11:458–463
Golombok S (2000) Parenting – what really counts? Taylor & Francis Group, London/Philadelphia
Golombok S, Brewaeys A, Cook R, Giavazzi MT, Guerra D, Mantovani A, van HE, Crosignani PG, Dexeus S (1996) The European study of assisted reproduction families: family functioning and child development. Hum Reprod 11:2324–2331
Hammarberg K, Astbury J, Baker H (2001) Women’s experience of IVF: a follow-up study. Hum Reprod 16:374–383
Hannibal CG, Jensen A, Sharif H, Kjaer SK (2008) Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 23:451–456
Hjelmstedt A, Widstrom A, Wramsby HM, Collins A (2003a) Patterns of emotional responses to pregnancy, experience of pregnancy and attitudes to parenthood among IVF couples: a longitudinal study. J Psychosom Obstet Gynaecol 24:153–162
Hjelmstedt A, Widstrom AM, Wramsby H, Matthiesen AS, Collins A (2003b) Personality factors and emotional responses to pregnancy among IVF couples in early pregnancy: a comparative study. Acta Obstet Gynecol Scand 82:152–161
Jensen A, Sharif H, Frederiksen K, Kjaer SK (2009) Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study. BMJ 338:b249
Kashyap S, Moher D, Fung MF, Rosenwaks Z (2004) Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis. Obstet Gynecol 103:785–794
Klip H (2002) Long-term health effects of subfertility treatment, the Netherlands. PrintPartners Ipskamp, Enschede
Klip H, van Leeuwen FE, Schats R, Burger CW (2003) Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women. Hum Reprod 18:1951–1958
Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW (1990) An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223–234
Kristiansson P, Bjor O, Wramsby H (2007) Tumour incidence in Swedish women who gave birth following IVF treatment. Hum Reprod 22:421–426
Kvaskoff M, Bijon A, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Cutaneous melanoma and endogenous hormonal factors: a large French prospective study. Am J Epidemiol 173(10):1192–1202
La Vecchia C, Ron E, Franceschi S, Dal ML, Mark SD, Chatenoud L, Braga C, Preston-Martin S, McTiernan A, Kolonel L et al (1999) A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10:157–166
Leiblum SR, Aviv A, Hamer R (1998) Life after infertility treatment: a long-term investigation of marital and sexual function. Hum Reprod 13:3569–3574
Litt MD, Tennen H, Affleck G, Klock S (1992) Coping and cognitive factors in adaptation to in vitro fertilization failure. J Behav Med 15:171–187
Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, Koch L, Smith Y, Stern JE, Ball GD, Schymura MJ (2015) Cancer in women after assisted reproductive technology. Fertil Steril 104:1218–1226
Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147:1038–1042
Newton CR, Hearn MT, Yuzpe AA (1990) Psychological assessment and follow-up after in vitro fertilization: assessing the impact of failure. Fertil Steril 54:879–886
Owen L, Golombok S (2009) Families created by assisted reproduction: parent-child relationships in late adolescence. J Adolesc 32:835–848
Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331:771–776
Schröder AK, Katalinic A, Diedrich K, Ludwig M (2004) Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod BioMed Online 8:600–606
Sergentanis TN, Diamantaras A-A, Perlepe C, Kanavidis P, Skalkidou A, Petridou ET (2014) IVF and breast cancer: a systematic review and meta-analysis. Hum Reprod Update 20:106–123
Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG (1996) Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 65:13–18
Slade P, Emery J, Lieberman BA (1997) A prospective, longitudinal study of emotions and relationships in in-vitro fertilization treatment. Hum Reprod 12:183–190
Spaan M, van den Belt-Dusebout AW, Schaapveld M, Mooij TM, Burger CW, van Leeuwen FE, on Behalf of the OMEGA-Project Group (2015) Melanoma risk after ovarian stimulation for in vitro fertilization. Hum Reprod 30:1216–1228
Sydsjo G, Svanberg AS, Lampic C, Jablonowska B (2011) Relationships in IVF couples 20 years after treatment. Hum Reprod 26:1836
Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff C, Niwa S, Brinton LA (2013) Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large US infertility cohort. Fertil Steril 100:1660–1666
Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586–1590
Venn A, Hemminki E, Watson L, Bruinsma F, Healy D (2001) Mortality in a cohort of IVF patients. Hum Reprod 16:2691–2696
Weaver SM, Clifford E, Hay DM, Robinson J (1997) Psychosocial adjustment to unsuccessful IVF and GIFT treatment. Patient Educ Couns 31:7–18
Whittemore AS (1993) Fertility drugs and risk of ovarian cancer. Hum Reprod 8:999–1000
Wirtberg I, Moller A, Hogstrom L, Tronstad SE, Lalos A (2007) Life 20 years after unsuccessful infertility treatment. Hum Reprod 22:598–604
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Ludwig, M. (2018). Langzeit-Follow-up von Patientinnen nach ovarieller Stimulation und Kinderwunschtherapien. In: Diedrich, K., Ludwig, M., Griesinger, G. (eds) Reproduktionsmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55601-6_51-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-55601-6_51-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55601-6
Online ISBN: 978-3-662-55601-6
eBook Packages: Springer Referenz Medizin